Form 8-K - Current report:
SEC Accession No. 0001104659-25-058523
Filing Date
2025-06-11
Accepted
2025-06-11 16:01:46
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517681d1_8k.htm   iXBRL 8-K 31992
  Complete submission text file 0001104659-25-058523.txt   197841

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20250610.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20250610_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20250610_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2517681d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 251039878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)